Why do Clinical Trails Fail and How we can prevent? HaleUs February 5, 2025 Clinical trial management for pharmaceuticals and medical devices is a complex, resource-intensive endeavor. Many factors contribute to trial failures, including
Demystifying the 505(b)(2) Pathway: A Guide to Accelerated Regulatory Submissions HaleUs January 28, 2025 In the evolving phase of drug development, the establishment of 505(b)(2) new drug application (NDA) process offers mid-sized small molecule